Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Dec 27, 2023; 15(12): 2727-2738
Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2727
Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2727
Non-HCC | HCC | |||||||
Univariate | Multivariate | Univariate | Multivariate | |||||
HR (95%CI) | P value | HR (95%CI) | P value | HR (95%CI) | P value | HR (95%CI) | P value | |
B cell crossmatching, positive | 0.19 (0.05-0.73) | 0.016 | NS | |||||
Tacrolimus level, post-LT 24 week | 0.42 (0.23-0.88) | 0.019 | 0.46 (0.23-0.91) | 0.026 | ||||
AMR | 3.39 (0.70-16.36) | 0.099 | NS | 11.33 (2.88-44.57) | 0.001 | 63.20 (6.49-614.78) | < 0.001 | |
HCC recurrence | 5.31 (1.48-19.02) | 0.010 | 20.72 (2.48-173.32) | 0.005 |
- Citation: Han JW, Choi JY, Jung ES, Kim JH, Cho HS, Yoo JS, Sung PS, Jang JW, Yoon SK, Choi HJ, You YK. Association between the early high level of serum tacrolimus and recurrence of hepatocellular carcinoma in ABO-incompatible liver transplantation. World J Gastrointest Surg 2023; 15(12): 2727-2738
- URL: https://www.wjgnet.com/1948-9366/full/v15/i12/2727.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i12.2727